While we encourage the impacted MIPS eligible clinician to take steps to ensure data submission for subsequent years, by, for example, selecting an alternate third party intermediary, there may be cases where there is insufficient time for the MIPS eligible clinician to submit the data through an alternative mechanism in time for the data to be considered for the relevant performance period
(1) Subject to paragraph (b) of this section, the total rebate amount to be paid by a manufacturer for a Part D rebatable drug, as identified under 428.101, for an applicable period is equal to: ( (i) The product of the per unit Part D rebate amount of such drug, as determined under 428.202(a), and the total number of units dispensed of such drug under Part D, as determined under 428.203
(ii) For the applicable period beginning October 1, 2023, the applicable threshold is equal to $100 increased by the percentage increase in CPI-U for the 12-month period beginning October 1, 2023
The medical benefits of the products is still in the research phase
Il n'y a plus d'arguments pour dire que votre skate ne vous plait pas
